AU2023269081A1 - Crystalline forms of a tyk2 inhibitor and uses thereof - Google Patents

Crystalline forms of a tyk2 inhibitor and uses thereof Download PDF

Info

Publication number
AU2023269081A1
AU2023269081A1 AU2023269081A AU2023269081A AU2023269081A1 AU 2023269081 A1 AU2023269081 A1 AU 2023269081A1 AU 2023269081 A AU2023269081 A AU 2023269081A AU 2023269081 A AU2023269081 A AU 2023269081A AU 2023269081 A1 AU2023269081 A1 AU 2023269081A1
Authority
AU
Australia
Prior art keywords
crystalline form
powder
ray diffraction
diffraction pattern
degrees
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023269081A
Other languages
English (en)
Inventor
Kolbot By
Travis Remarchuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alumis Inc
Original Assignee
Alumis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alumis Inc filed Critical Alumis Inc
Publication of AU2023269081A1 publication Critical patent/AU2023269081A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2023269081A 2022-05-13 2023-05-12 Crystalline forms of a tyk2 inhibitor and uses thereof Pending AU2023269081A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263341528P 2022-05-13 2022-05-13
US63/341,528 2022-05-13
US202263405577P 2022-09-12 2022-09-12
US63/405,577 2022-09-12
PCT/US2023/021986 WO2023220338A1 (en) 2022-05-13 2023-05-12 Crystalline forms of a tyk2 inhibitor and uses thereof

Publications (1)

Publication Number Publication Date
AU2023269081A1 true AU2023269081A1 (en) 2024-11-28

Family

ID=86760338

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023269081A Pending AU2023269081A1 (en) 2022-05-13 2023-05-12 Crystalline forms of a tyk2 inhibitor and uses thereof

Country Status (12)

Country Link
US (1) US20260209205A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522602A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025516683A (cg-RX-API-DMAC7.html)
KR (1) KR20250009492A (cg-RX-API-DMAC7.html)
CN (1) CN119907791A (cg-RX-API-DMAC7.html)
AU (1) AU2023269081A1 (cg-RX-API-DMAC7.html)
CA (1) CA3253365A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024003456A1 (cg-RX-API-DMAC7.html)
IL (1) IL317011A (cg-RX-API-DMAC7.html)
MX (1) MX2024014000A (cg-RX-API-DMAC7.html)
TW (1) TW202409007A (cg-RX-API-DMAC7.html)
WO (1) WO2023220338A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202428571A (zh) * 2022-10-10 2024-07-16 美商雅盧米斯公司 Tyk2抑制劑之晶型及其用途
WO2026019902A1 (en) * 2024-07-16 2026-01-22 Alumis Inc. Crystalline forms of a tyk2 inhibitor and uses thereof
WO2026128621A2 (en) * 2024-12-12 2026-06-18 Alumis Inc. Process of making tyk2 inhibitors and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS66346B1 (sr) * 2018-10-22 2025-01-31 Alumis Inc Inhibitori tyk2 i njihova upotreba

Also Published As

Publication number Publication date
KR20250009492A (ko) 2025-01-17
WO2023220338A1 (en) 2023-11-16
EP4522602A1 (en) 2025-03-19
IL317011A (en) 2025-01-01
TW202409007A (zh) 2024-03-01
MX2024014000A (es) 2025-02-10
US20260209205A1 (en) 2026-07-23
JP2025516683A (ja) 2025-05-30
CL2024003456A1 (es) 2025-04-25
CN119907791A (zh) 2025-04-29
CA3253365A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
WO2023220338A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
EP3216790B1 (en) Crystalline form of jak kinase inhibitor bisulfate and a preparation method thereof
EP1866286A1 (en) Pyridine derivatives useful as inhibitors of pkc-theta
WO2007091703A1 (en) N-hydroxyacrylamide compounds
US20250376459A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
WO2016151304A1 (en) Novel polymorphic form x of nilotinib dihydrochloride hydrate
US20250263378A1 (en) Solid forms
US20260138965A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
WO2026019902A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
WO2026019908A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
US20240368185A1 (en) Macrocyclic azolopyridines
WO2026019900A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
CN110903291B (zh) 一种杂芳基并[4,3-c]嘧啶-5-胺类衍生物的盐、盐的晶型及制备方法
CN115772123A (zh) 固体形式
CN117120425A (zh) 鞘氨醇-1-磷酸酯受体激动剂的晶体形式